Two-Year trial tests Long-Term safety of gut hormone treatment
NCT ID NCT07228403
Summary
This study follows patients with short bowel syndrome for two years to see if continuing treatment with glepaglutide remains safe and effective. It includes 35 adults who were already receiving this medication in previous trials. The main goal is to monitor side effects and see if the treatment continues to help reduce the need for intravenous nutrition support.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME (SBS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HP - Hôpital Beaujon
Clichy, Hauts-de-Seine, 92118, France
-
Asklepios Klinik St. Georg
Hamburg, 20099, Germany
-
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, 10117, Germany
-
Cleveland Clinic-9500 Euclid Ave
Cleveland, Ohio, 44195-0001, United States
-
LHSC - University Hospital
London, Ontario, N6A 4V2, Canada
-
Lied Transplant Center at Nebraska Medical Center
Omaha, Nebraska, 68105, United States
-
Mayo Clinic - PPDS
Rochester, Minnesota, 55905-0001, United States
-
Samodzielny Publiczny Szpitala Kliniczny im. Prof. Witolda Orlowskiego CMKP
Warsaw, Masovian Voivodeship, 00-416, Poland
-
St Mark's Hospital (Central Middlesex Hospital)
Ealing, NW10 7NS, United Kingdom
-
Szpital Skawina sp. z o.o. im. Stanley Dudricka
Skawina, Lesser Poland Voivodeship, 32-050, Poland
-
UZ Leuven - PPDS
Leuven, 3000, Belgium
-
Universitätsklinikum Bonn
Bonn, North Rhine-Westphalia, 53127, Germany
-
Universitätsklinikum Frankfurt
Frankfurt am Main, Hesse, 60590, Germany
-
Universitätsmedizin Rostock
Rostock, Mecklenburg-Vorpommern, 18057, Germany
-
Vanderbilt University Medical Center-Tennesse-1211 21st Ave S
Nashville, Tennessee, 37212-2700, United States
-
Wojewódzki Szpital Specjalistycznyo im. M. Pirogowa w Lodzi
Lodz, 90-531, Poland
Conditions
Explore the condition pages connected to this study.